Trials / Completed
CompletedNCT04645004
Antenatal Platelet Response on Aspirin: a Pharmacokinetic Study Through Pregnancy
Impact of Maternal Aspirin Tehrapy on the Maternal/Fetal Unit at Delivery: a Study of Aspirin Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics Through Pregnancy
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Thomas Jefferson University · Academic / Other
- Sex
- Female
- Age
- 13 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
Longitudinal pharmacokinetic and pharmacodynamic study in first and third trimester of pregnancy
Detailed description
This will be a longitudinal addition to an existing R21cohort enrolled in the first trimester to include a first and third trimester assessment of pharmacokinetics/pharmacodynamics (PK/PD) of aspirin and how individual factors impact aspirin PK/PD in pregnancy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aspirin 81Mg Non-enteric coated Tab | one tab daily |
Timeline
- Start date
- 2020-12-29
- Primary completion
- 2024-01-11
- Completion
- 2024-03-15
- First posted
- 2020-11-25
- Last updated
- 2024-04-18
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04645004. Inclusion in this directory is not an endorsement.